SPR Therapeutics acquired by Medtronic
Medtronic agreed to acquire SPR Therapeutics, a medtech brand, on May 20, 2026.
Preliminary: The announcement date, value basis and value notes are not yet independently verified.
Transaction summary
- Target
- SPR Therapeutics
- Acquirer
- Medtronic
- Seller
- -
- Announced
- 2026-05-20(unverified)
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-07-13
- Latest update
- 2026-10-29
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed | USD
Basis: Undisclosed
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Enterprise value is unavailable.
Source summary
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain - PR Newswire
ConfirmedPR Newswire announcement dated May 20, 2026 states that Medtronic intends to acquire SPR Therapeutics, a chronic pain-focused medical technology company.
Open sourceContinue your research
Related transaction comps
CathWorks acquired by Medtronic
2026-04-20 · Confirmed
View transaction → medical devicesAvanos Medical, Inc. acquired by American Industrial Partners
2026-07-27 · Confirmed
View transaction → medical devicesAmplitude Vascular Systems acquired by Stryker
2026-04-13 · Confirmed
View transaction → MedtechIMATS acquired by Command Medical
- · Confirmed
View transaction →